CA2082495A1 - Preparation pharmaceutique contenant des n-glycofuroles et des n-ethylene-glycols - Google Patents

Preparation pharmaceutique contenant des n-glycofuroles et des n-ethylene-glycols

Info

Publication number
CA2082495A1
CA2082495A1 CA002082495A CA2082495A CA2082495A1 CA 2082495 A1 CA2082495 A1 CA 2082495A1 CA 002082495 A CA002082495 A CA 002082495A CA 2082495 A CA2082495 A CA 2082495A CA 2082495 A1 CA2082495 A1 CA 2082495A1
Authority
CA
Canada
Prior art keywords
glycofurols
pharmaceutical preparation
ethylene glycols
preparation containing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002082495A
Other languages
English (en)
Other versions
CA2082495C (fr
Inventor
Erik Bechgaard
Sveinbjorn Gizurarson
Rolf K. Hjortkjaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lyfjathroun Hf Biopharmaceuticals
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK117090A external-priority patent/DK117090D0/da
Priority claimed from DK207590A external-priority patent/DK207590D0/da
Application filed by Individual filed Critical Individual
Priority claimed from PCT/DK1991/000119 external-priority patent/WO1991016929A1/fr
Publication of CA2082495A1 publication Critical patent/CA2082495A1/fr
Application granted granted Critical
Publication of CA2082495C publication Critical patent/CA2082495C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002082495A 1990-05-10 1991-05-03 Preparation pharmaceutique contenant des n-glycofuroles et des n-ethylene-glycols Expired - Fee Related CA2082495C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK1170/90 1990-05-10
DK117090A DK117090D0 (da) 1990-05-10 1990-05-10 Composition for intranasal administration of biol ogically active benzodiazepine compounds
DK2075/90 1990-08-30
DK207590A DK207590D0 (da) 1990-08-30 1990-08-30 Farmaceutisk praeparat
PCT/DK1991/000119 WO1991016929A1 (fr) 1990-05-10 1991-05-03 PREPARATION PHARMACEUTIQUE CONTENANT DES n-GLYCOFUROLS ET DES n-ETHYLENE GLYCOLS

Publications (2)

Publication Number Publication Date
CA2082495A1 true CA2082495A1 (fr) 1991-11-11
CA2082495C CA2082495C (fr) 2006-10-03

Family

ID=37101712

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002082495A Expired - Fee Related CA2082495C (fr) 1990-05-10 1991-05-03 Preparation pharmaceutique contenant des n-glycofuroles et des n-ethylene-glycols

Country Status (1)

Country Link
CA (1) CA2082495C (fr)

Also Published As

Publication number Publication date
CA2082495C (fr) 2006-10-03

Similar Documents

Publication Publication Date Title
AU7880991A (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
CA2044746A1 (fr) Compose peptideque et son processus de preparation
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
EP0564739A3 (fr)
MY101784A (en) Novel pharmacological compounds
CA2040982A1 (fr) Derives n-(3-fluoro-2-phosphonylmethoxypropyle) des bases heterocycliques purine et pyrimidine, methode pour leur production et utilisation comme principes actifs de medicaments
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL105646A0 (en) Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them
CA2179733A1 (fr) Sulfamates de pseudofructopyranose anticonvulsifs
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
NO177714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
CA2082495A1 (fr) Preparation pharmaceutique contenant des n-glycofuroles et des n-ethylene-glycols
AU640241B2 (en) Ws7622a mono- or di-sulfate, process for preparation thereof and use thereof
ES2145740T3 (es) Composiciones de factor de crecimiento, preparacion y uso.
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
CA2022323A1 (fr) Excretion d'ions potassium par des derives de l'acide prostanoique
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
IT1270122B (it) 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
KR890014745A (ko) Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물
JPS5742620A (en) Novel antiulcer agent

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed